STRO vs TRV · rev $62.0M vs P/E 14, rev $46.42B
Sutro Biopharma (STRO) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
Latest reported TRV revenue for 2024-12-31 was $46.42B. Net income was $5.00B. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
STRO currently screens at market cap $470.8M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the STRO and TRV stock pages for the full models.
Not investment advice.